glp-1 drugs for weight loss Another Weight-Loss Trial Win Weekly Drug Popular GLP-1 medications may have

Circulation (2024)

Furthermore, as a result of their pleiotropic effect on multiple organ systems, these agents are emerging as potential therapy for metabolic dysfunction-associated steatotic liver disease, neurodegenerative conditions, and behavioral health disorders [5, 6]

However, much more research is needed in this area before we can draw firm conclusions or incorporate GLP-1 therapy routinely into male fertility care

Zelniker TA, Wiviott SD, Raz I et al (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Diabetes Obes Metab 23(3):754762 Vilsbll T, Garber AJ (2012) Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide

For stakeholders across healthcare, the challenge is clear: keep ahead of the obesity market changes, adapt strategies, and seize opportunities in this rapidly evolving landscape